https://www.selleckchem.com/pr....oducts/cct241533-hyd
n-progressive disease at +12months, with reduced pain, better functional status, and encouraging long-term disease control. Cryoablation demonstrated feasibility in progressive DT pts. The study met is primary end-point with 86% of non-progressive disease at +12 months, with reduced pain, better functional status, and encouraging long-term disease control.White matter fiber tracts demonstrate heterogeneous vulnerabilities to aging effects. Here, we estimated age-related differences in tract properties using UK Biobank di
Like
Comment
Share
